Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection
Nakayama M, Marchi H, Dmitrieva AM, Chakraborty A, Merl-Pham J, Hennen E, Le Gleut R, Ruppert C, Guenther A, Kahnert K, Behr J, et al. (2023)
Frontiers in Microbiology 13: 957830.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
fmicb-13-957830.pdf
6.68 MB
Autor*in
Nakayama, Misako;
Marchi, HannahUniBi ;
Dmitrieva, Anna M.;
Chakraborty, Ashesh;
Merl-Pham, Juliane;
Hennen, Elisabeth;
Le Gleut, Ronan;
Ruppert, Clemens;
Guenther, Andreas;
Kahnert, Kathrin;
Behr, Jürgen;
Hilgendorff, Anne
Alle
Alle
Abstract / Bemerkung
**Background**
Chronic obstructive pulmonary disease (COPD) collectively refers to chronic and progressive lung diseases that cause irreversible limitations in airflow. Patients with COPD are at high risk for severe respiratory symptoms upon influenza virus infection. Airway epithelial cells provide the first-line antiviral defense, but whether or not their susceptibility and response to influenza virus infection changes in COPD have not been elucidated. Therefore, this study aimed to compare the susceptibility of COPD- and control-derived airway epithelium to the influenza virus and assess protein changes during influenza virus infection by quantitative proteomics. **Materials and methods**
The presence of human- and avian-type influenza A virus receptor was assessed in control and COPD lung sections as well as in fully differentiated primary human bronchial epithelial cells (phBECs) by lectin- or antibody-based histochemical staining. PhBECs were from COPD lungs, including cells from moderate- and severe-stage diseases, and from age-, sex-, smoking, and history-matched control lung specimens. Protein profiles pre- and post-influenza virus infectionin vitrowere directly compared using quantitative proteomics, and selected findings were validated by qRT-PCR and immunoblotting. **Results**
The human-type influenza receptor was more abundant in human airways than the avian-type influenza receptor, a property that was retainedin vitrowhen differentiating phBECs at the air–liquid interface. Proteomics of phBECs pre- and post-influenza A virus infection with A/Puerto Rico/8/34 (PR8) revealed no significant differences between COPD and control phBECs in terms of flu receptor expression, cell type composition, virus replication, or protein profile pre- and post-infection. Independent of health state, a robust antiviral response to influenza virus infection was observed, as well as upregulation of several novel influenza virus-regulated proteins, including PLSCR1, HLA-F, CMTR1, DTX3L, and SHFL. **Conclusion**
COPD- and control-derived phBECs did not differ in cell type composition, susceptibility to influenza virus infection, and proteomes pre- and post-infection. Finally, we identified novel influenza A virus-regulated proteins in bronchial epithelial cells that might serve as potential targets to modulate the pathogenicity of infection and acute exacerbations.
Chronic obstructive pulmonary disease (COPD) collectively refers to chronic and progressive lung diseases that cause irreversible limitations in airflow. Patients with COPD are at high risk for severe respiratory symptoms upon influenza virus infection. Airway epithelial cells provide the first-line antiviral defense, but whether or not their susceptibility and response to influenza virus infection changes in COPD have not been elucidated. Therefore, this study aimed to compare the susceptibility of COPD- and control-derived airway epithelium to the influenza virus and assess protein changes during influenza virus infection by quantitative proteomics. **Materials and methods**
The presence of human- and avian-type influenza A virus receptor was assessed in control and COPD lung sections as well as in fully differentiated primary human bronchial epithelial cells (phBECs) by lectin- or antibody-based histochemical staining. PhBECs were from COPD lungs, including cells from moderate- and severe-stage diseases, and from age-, sex-, smoking, and history-matched control lung specimens. Protein profiles pre- and post-influenza virus infectionin vitrowere directly compared using quantitative proteomics, and selected findings were validated by qRT-PCR and immunoblotting. **Results**
The human-type influenza receptor was more abundant in human airways than the avian-type influenza receptor, a property that was retainedin vitrowhen differentiating phBECs at the air–liquid interface. Proteomics of phBECs pre- and post-influenza A virus infection with A/Puerto Rico/8/34 (PR8) revealed no significant differences between COPD and control phBECs in terms of flu receptor expression, cell type composition, virus replication, or protein profile pre- and post-infection. Independent of health state, a robust antiviral response to influenza virus infection was observed, as well as upregulation of several novel influenza virus-regulated proteins, including PLSCR1, HLA-F, CMTR1, DTX3L, and SHFL. **Conclusion**
COPD- and control-derived phBECs did not differ in cell type composition, susceptibility to influenza virus infection, and proteomes pre- and post-infection. Finally, we identified novel influenza A virus-regulated proteins in bronchial epithelial cells that might serve as potential targets to modulate the pathogenicity of infection and acute exacerbations.
Erscheinungsjahr
2023
Zeitschriftentitel
Frontiers in Microbiology
Band
13
Art.-Nr.
957830
Urheberrecht / Lizenzen
eISSN
1664-302X
Page URI
https://pub.uni-bielefeld.de/record/2968563
Zitieren
Nakayama M, Marchi H, Dmitrieva AM, et al. Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection. Frontiers in Microbiology. 2023;13: 957830.
Nakayama, M., Marchi, H., Dmitrieva, A. M., Chakraborty, A., Merl-Pham, J., Hennen, E., Le Gleut, R., et al. (2023). Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection. Frontiers in Microbiology, 13, 957830. https://doi.org/10.3389/fmicb.2022.957830
Nakayama, Misako, Marchi, Hannah, Dmitrieva, Anna M., Chakraborty, Ashesh, Merl-Pham, Juliane, Hennen, Elisabeth, Le Gleut, Ronan, et al. 2023. “Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection”. Frontiers in Microbiology 13: 957830.
Nakayama, M., Marchi, H., Dmitrieva, A. M., Chakraborty, A., Merl-Pham, J., Hennen, E., Le Gleut, R., Ruppert, C., Guenther, A., Kahnert, K., et al. (2023). Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection. Frontiers in Microbiology 13:957830.
Nakayama, M., et al., 2023. Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection. Frontiers in Microbiology, 13: 957830.
M. Nakayama, et al., “Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection”, Frontiers in Microbiology, vol. 13, 2023, : 957830.
Nakayama, M., Marchi, H., Dmitrieva, A.M., Chakraborty, A., Merl-Pham, J., Hennen, E., Le Gleut, R., Ruppert, C., Guenther, A., Kahnert, K., Behr, J., Hilgendorff, A., Hauck, S.M., Adler, H., Staab-Weijnitz, C.A.: Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection. Frontiers in Microbiology. 13, : 957830 (2023).
Nakayama, Misako, Marchi, Hannah, Dmitrieva, Anna M., Chakraborty, Ashesh, Merl-Pham, Juliane, Hennen, Elisabeth, Le Gleut, Ronan, Ruppert, Clemens, Guenther, Andreas, Kahnert, Kathrin, Behr, Jürgen, Hilgendorff, Anne, Hauck, Stefanie M., Adler, Heiko, and Staab-Weijnitz, Claudia A. “Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection”. Frontiers in Microbiology 13 (2023): 957830.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
fmicb-13-957830.pdf
6.68 MB
Access Level
Open Access
Zuletzt Hochgeladen
2023-01-31T16:40:22Z
MD5 Prüfsumme
d6977ae17d833b9a974209c2ae5d910b
Link(s) zu Volltext(en)
Access Level
Open Access
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 36713229
PubMed | Europe PMC
Suchen in